Literature DB >> 29884888

DNA mismatch repair protein deficient non-neoplastic colonic crypts: a novel indicator of Lynch syndrome.

Rish K Pai1, Beth Dudley2, Eve Karloski2, Randall E Brand2, Neil O'Callaghan3,4, Christophe Rosty3,4,5,6, Daniel D Buchanan3,4,7, Mark A Jenkins8, Stephen N Thibodeau9, Amy J French9, Noralane M Lindor10, Reetesh K Pai11.   

Abstract

Lynch syndrome is the most common form of hereditary colorectal carcinoma. However, establishing the diagnosis of Lynch syndrome is challenging, and ancillary studies that distinguish between sporadic DNA mismatch repair (MMR) protein deficiency and Lynch syndrome are needed, particularly when germline mutation studies are inconclusive. The aim of this study was to determine if MMR protein-deficient non-neoplastic intestinal crypts can help distinguish between patients with and without Lynch syndrome. We evaluated the expression of MMR proteins in non-neoplastic intestinal mucosa obtained from colorectal surgical resection specimens from patients with Lynch syndrome-associated colorectal carcinoma (n = 52) and patients with colorectal carcinoma without evidence of Lynch syndrome (n = 70), including sporadic MMR protein-deficient colorectal carcinoma (n = 30), MMR protein proficient colorectal carcinoma (n = 30), and "Lynch-like" syndrome (n = 10). MMR protein-deficient non-neoplastic colonic crypts were identified in 19 of 122 (16%) patients. MMR protein-deficient colonic crypts were identified in 18 of 52 (35%) patients with Lynch syndrome compared to only 1 of 70 (1%) patients without Lynch syndrome (p < 0.001). This one patient had "Lynch-like" syndrome and harbored two MSH2-deficient non-neoplastic colonic crypts. MMR protein-deficient non-neoplastic colonic crypts were not identified in patients with sporadic MMR protein-deficient or MMR protein proficient colorectal carcinoma. Our findings suggest that MMR protein-deficient colonic crypts are a novel indicator of Lynch syndrome, and evaluation for MMR protein-deficient crypts may be a helpful addition to Lynch syndrome diagnostics.

Entities:  

Mesh:

Year:  2018        PMID: 29884888      PMCID: PMC6396289          DOI: 10.1038/s41379-018-0079-6

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  31 in total

1.  Prevalence of germline MUTYH mutations among Lynch-like syndrome patients.

Authors:  Adela Castillejo; Gardenia Vargas; María Isabel Castillejo; Matilde Navarro; Víctor Manuel Barberá; Sara González; Eva Hernández-Illán; Joan Brunet; Teresa Ramón y Cajal; Judith Balmaña; Silvestre Oltra; Sílvia Iglesias; Angela Velasco; Ares Solanes; Olga Campos; Ana Beatriz Sánchez Heras; Javier Gallego; Estela Carrasco; Dolors González Juan; Angel Segura; Isabel Chirivella; María José Juan; Isabel Tena; Conxi Lázaro; Ignacio Blanco; Marta Pineda; Gabriel Capellá; José Luis Soto
Journal:  Eur J Cancer       Date:  2014-06-18       Impact factor: 9.162

2.  Challenging cases encountered in colorectal cancer screening for Lynch syndrome reveal novel findings: nucleolar MSH6 staining and impact of prior chemoradiation therapy.

Authors:  Oana M Radu; Marina N Nikiforova; Linda M Farkas; Alyssa M Krasinskas
Journal:  Hum Pathol       Date:  2011-02-21       Impact factor: 3.466

Review 3.  Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer.

Authors:  Francis M Giardiello; John I Allen; Jennifer E Axilbund; C Richard Boland; Carol A Burke; Randall W Burt; James M Church; Jason A Dominitz; David A Johnson; Tonya Kaltenbach; Theodore R Levin; David A Lieberman; Douglas J Robertson; Sapna Syngal; Douglas K Rex
Journal:  Gastroenterology       Date:  2014-08       Impact factor: 22.682

4.  Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting.

Authors:  Lucia I H Overbeek; Marjolijn J L Ligtenberg; Riki W Willems; Rosella P M G Hermens; Willeke A M Blokx; Stefan V Dubois; Hans van der Linden; Jos W R Meijer; Maria L Mlynek-Kersjes; Nicoline Hoogerbrugge; Konnie M Hebeda; Joannes H J M van Krieken
Journal:  Am J Surg Pathol       Date:  2008-08       Impact factor: 6.394

5.  Defining the adenoma burden in lynch syndrome.

Authors:  Matthew F Kalady; Sara E Kravochuck; Brandie Heald; Carol A Burke; James M Church
Journal:  Dis Colon Rectum       Date:  2015-04       Impact factor: 4.585

6.  Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer.

Authors:  Andrea E de Jong; Marjo van Puijenbroek; Yvonne Hendriks; Carli Tops; Juul Wijnen; Margreet G E M Ausems; Hanne Meijers-Heijboer; Anja Wagner; Theo A M van Os; Annette H J T Bröcker-Vriends; Hans F A Vasen; Hans Morreau
Journal:  Clin Cancer Res       Date:  2004-02-01       Impact factor: 12.531

7.  The histopathology of BRAF-V600E-mutated lung adenocarcinoma.

Authors:  Samuel A Yousem; Marina Nikiforova; Yuri Nikiforov
Journal:  Am J Surg Pathol       Date:  2008-09       Impact factor: 6.394

8.  Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients.

Authors:  Michael D Walsh; Margaret C Cummings; Daniel D Buchanan; Wendy M Dambacher; Sven Arnold; Diane McKeone; Rebecca Byrnes; Melissa A Barker; Barbara A Leggett; Michael Gattas; Jeremy R Jass; Amanda B Spurdle; Joanne Young; Andreas Obermair
Journal:  Clin Cancer Res       Date:  2008-02-29       Impact factor: 12.531

9.  Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer.

Authors:  Fadwa A Elsayed; C Marleen Kets; Dina Ruano; Brendy van den Akker; Arjen R Mensenkamp; Melanie Schrumpf; Maartje Nielsen; Juul T Wijnen; Carli M Tops; Marjolijn J Ligtenberg; Hans F A Vasen; Frederik J Hes; Hans Morreau; Tom van Wezel
Journal:  Eur J Hum Genet       Date:  2014-11-05       Impact factor: 4.246

10.  Mismatch repair-deficient crypt foci in Lynch syndrome--molecular alterations and association with clinical parameters.

Authors:  Laura Staffa; Fabian Echterdiek; Nina Nelius; Axel Benner; Wiebke Werft; Bernd Lahrmann; Niels Grabe; Martin Schneider; Mirjam Tariverdian; Magnus von Knebel Doeberitz; Hendrik Bläker; Matthias Kloor
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

View more
  6 in total

1.  Frequent loss of mutation-specific mismatch repair protein expression in nonneoplastic endometrium of Lynch syndrome patients.

Authors:  Serena Wong; Pei Hui; Natalia Buza
Journal:  Mod Pathol       Date:  2020-01-13       Impact factor: 7.842

2.  Detection of DNA mismatch repair deficient crypts in random colonoscopic biopsies identifies Lynch syndrome patients.

Authors:  Randall E Brand; Beth Dudley; Eve Karloski; Rohit Das; Kimberly Fuhrer; Rish K Pai; Reetesh K Pai
Journal:  Fam Cancer       Date:  2020-04       Impact factor: 2.375

3.  Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors.

Authors:  Berbel L M Ykema; Lisanne S Rigter; Manon C W Spaander; Leon M G Moons; Tanya M Bisseling; Berthe M P Aleman; Evelien Dekker; Wieke H M Verbeek; Ernst J Kuipers; Jan Paul de Boer; Pieternella J Lugtenburg; Cecile P M Janus; Eefke J Petersen; Judith M Roesink; Richard W M van der Maazen; Gerrit A Meijer; Michael Schaapveld; Flora E van Leeuwen; Beatriz Carvalho; Petur Snaebjornsson; Monique E van Leerdam
Journal:  Dig Endosc       Date:  2021-06-08       Impact factor: 6.337

4.  High endothelial venules are associated with microsatellite instability, hereditary background and immune evasion in colorectal cancer.

Authors:  Pauline L Pfuderer; Alexej Ballhausen; Florian Seidler; Hans-Jürgen Stark; Niels Grabe; Ian M Frayling; Ann Ager; Magnus von Knebel Doeberitz; Matthias Kloor; Aysel Ahadova
Journal:  Br J Cancer       Date:  2019-07-30       Impact factor: 7.640

Review 5.  Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors.

Authors:  Julie Leclerc; Catherine Vermaut; Marie-Pierre Buisine
Journal:  Cancers (Basel)       Date:  2021-01-26       Impact factor: 6.639

6.  Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium.

Authors:  Pål Møller; Toni Seppälä; James G Dowty; Saskia Haupt; Mev Dominguez-Valentin; Lone Sunde; Inge Bernstein; Christoph Engel; Stefan Aretz; Maartje Nielsen; Gabriel Capella; Dafydd Gareth Evans; John Burn; Elke Holinski-Feder; Lucio Bertario; Bernardo Bonanni; Annika Lindblom; Zohar Levi; Finlay Macrae; Ingrid Winship; John-Paul Plazzer; Rolf Sijmons; Luigi Laghi; Adriana Della Valle; Karl Heinimann; Elizabeth Half; Francisco Lopez-Koestner; Karin Alvarez-Valenzuela; Rodney J Scott; Lior Katz; Ido Laish; Elez Vainer; Carlos Alberto Vaccaro; Dirce Maria Carraro; Nathan Gluck; Naim Abu-Freha; Aine Stakelum; Rory Kennelly; Des Winter; Benedito Mauro Rossi; Marc Greenblatt; Mabel Bohorquez; Harsh Sheth; Maria Grazia Tibiletti; Leonardo S Lino-Silva; Karoline Horisberger; Carmen Portenkirchner; Ivana Nascimento; Norma Teresa Rossi; Leandro Apolinário da Silva; Huw Thomas; Attila Zaránd; Jukka-Pekka Mecklin; Kirsi Pylvänäinen; Laura Renkonen-Sinisalo; Anna Lepisto; Päivi Peltomäki; Christina Therkildsen; Lars Joachim Lindberg; Ole Thorlacius-Ussing; Magnus von Knebel Doeberitz; Markus Loeffler; Nils Rahner; Verena Steinke-Lange; Wolff Schmiegel; Deepak Vangala; Claudia Perne; Robert Hüneburg; Aída Falcón de Vargas; Andrew Latchford; Anne-Marie Gerdes; Ann-Sofie Backman; Carmen Guillén-Ponce; Carrie Snyder; Charlotte K Lautrup; David Amor; Edenir Palmero; Elena Stoffel; Floor Duijkers; Michael J Hall; Heather Hampel; Heinric Williams; Henrik Okkels; Jan Lubiński; Jeanette Reece; Joanne Ngeow; Jose G Guillem; Julie Arnold; Karin Wadt; Kevin Monahan; Leigha Senter; Lene J Rasmussen; Liselotte P van Hest; Luigi Ricciardiello; Maija R J Kohonen-Corish; Marjolijn J L Ligtenberg; Melissa Southey; Melyssa Aronson; Mohd N Zahary; N Jewel Samadder; Nicola Poplawski; Nicoline Hoogerbrugge; Patrick J Morrison; Paul James; Grant Lee; Rakefet Chen-Shtoyerman; Ravindran Ankathil; Rish Pai; Robyn Ward; Susan Parry; Tadeusz Dębniak; Thomas John; Thomas van Overeem Hansen; Trinidad Caldés; Tatsuro Yamaguchi; Verónica Barca-Tierno; Pilar Garre; Giulia Martina Cavestro; Jürgen Weitz; Silke Redler; Reinhard Büttner; Vincent Heuveline; John L Hopper; Aung Ko Win; Noralane Lindor; Steven Gallinger; Loïc Le Marchand; Polly A Newcomb; Jane Figueiredo; Daniel D Buchanan; Stephen N Thibodeau; Sanne W Ten Broeke; Eivind Hovig; Sigve Nakken; Marta Pineda; Nuria Dueñas; Joan Brunet; Kate Green; Fiona Lalloo; Katie Newton; Emma J Crosbie; Miriam Mints; Douglas Tjandra; Florencia Neffa; Patricia Esperon; Revital Kariv; Guy Rosner; Walter Hernán Pavicic; Pablo Kalfayan; Giovana Tardin Torrezan; Thiago Bassaneze; Claudia Martin; Gabriela Moslein; Aysel Ahadova; Matthias Kloor; Julian R Sampson; Mark A Jenkins
Journal:  Hered Cancer Clin Pract       Date:  2022-10-01       Impact factor: 2.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.